Westlake Chemical WLKP
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$153.8K (4 inflow days, 16 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 66.5% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 0.34% to 0.42% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Raymond James Financial, Inc. | Public Company | 2026/Q3 | +50,527 | 0.2% |
| BNP Paribas Financial Markets SNC | Private Company | 2026/Q3 | +34,177 | 0.1% |
| Gilman Hill Asset Management, LLC | Mutual Fund | 2026/Q3 | +26,212 | 0.3% |
| Osaic Wealth, Inc. | Private Company | 2026/Q3 | +9,447 | 0.1% |
| Pathway Financial Advisers, LLC | Mutual Fund | 2026/Q3 | +6,348 | 0.3% |
| ClearBridge Investments, LLC | Mutual Fund | 2026/Q3 | +6,000 | 1.8% |
| Arrow Investment Advisors, LLC | Mutual Fund | 2026/Q3 | +1,555 | 0.0% |
| Mariner, LLC | Mutual Fund | 2026/Q3 | +1,506 | 0.0% |
| MGO One Seven LLC | Mutual Fund | 2026/Q3 | +1,160 | 0.0% |
| Pekin Hardy Strauss, Inc. | Mutual Fund | 2026/Q3 | +1,022 | 0.1% |
| Harbor Capital Advisors, Inc. | Mutual Fund | 2026/Q3 | +555 | 0.0% |
| CX Institutional, LLC | Family Office/Trust | 2026/Q3 | +500 | 0.0% |
| Harbor Capital Advisors, Inc. | Mutual Fund | 2026/Q3 | +960 | 0.0% |
| George Finley | Individual/Insider | 2026/Q3 | +5,005 | 0.1% |
| Lisa Friel | Individual/Insider | 2026/Q3 | +2,503 | 0.0% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 11 Aug 2026 | George Finley | Independent Director of Westlake Chemical Partners GP LLC | Other Derivative Acquisition | +5,044 | – | – |
| 11 Aug 2026 | Randy Woelfel | Independent Director of Westlake Chemical Partners GP LLC | Other Derivative Acquisition | +5,044 | – | – |
| 11 Aug 2026 | Lisa Friel | Independent Director of Westlake Chemical Partners GP LLC | Other Derivative Acquisition | +5,044 | – | – |
| 5 Aug 2026 | George Finley | Independent Director of Westlake Chemical Partners GP LLC | Derivative Exercise and Retained | +5,005 | – | 36,935 |
| 5 Aug 2026 | Randy Woelfel | Independent Director of Westlake Chemical Partners GP LLC | Derivative Exercise and Sale | -5,005 | $21.35 | 23,913 |
| 5 Aug 2026 | Lisa Friel | Independent Director of Westlake Chemical Partners GP LLC | Derivative Exercise and Sale | -2,502 | $21.35 | 9,666 |
| 5 Aug 2026 | Lisa Friel | Independent Director of Westlake Chemical Partners GP LLC | Derivative Exercise and Retained | +2,503 | – | 9,666 |
| 26 Aug 2025 | Jean-Marc Gilson | President, CEO & Director of Westlake Chemical Partners GP LLC | Private Acquisition | +95 | $21.25 | 11,803 |
| 6 Aug 2025 | George Finley | Independent Director of Westlake Chemical Partners GP LLC | Derivative Exercise and Retained | +4,882 | – | 31,930 |
| 6 Aug 2025 | Randy Woelfel | Independent Director of Westlake Chemical Partners GP LLC | Derivative Exercise and Sale | -4,882 | $21.96 | 23,913 |
| 6 Aug 2025 | Lisa Friel | Independent Director of Westlake Chemical Partners GP LLC | Derivative Exercise and Sale | -2,441 | $21.96 | 7,163 |
| 6 Aug 2025 | Lisa Friel | Independent Director of Westlake Chemical Partners GP LLC | Derivative Exercise and Retained | +2,441 | – | 7,163 |
| 5 Aug 2025 | George Finley | Independent Director of Westlake Chemical Partners GP LLC | Other Derivative Acquisition | +5,005 | – | – |
| 5 Aug 2025 | Randy Woelfel | Independent Director of Westlake Chemical Partners GP LLC | Other Derivative Acquisition | +5,005 | – | – |
| 5 Aug 2025 | Lisa Friel | Independent Director of Westlake Chemical Partners GP LLC | Other Derivative Acquisition | +5,005 | – | – |
| 28 May 2025 | James Chao | Senior Chairman of the Board of Westlake Chemical Partners GP LLC | Open Market Disposition | -3,700 | $22.10 | – |
| 27 May 2025 | James Chao | Senior Chairman of the Board of Westlake Chemical Partners GP LLC | Open Market Disposition | -10,208 | $22.17 | 3,700 |
| 26 May 2025 | James Chao | Senior Chairman of the Board of Westlake Chemical Partners GP LLC | Intent to Sell (Form 144) | -13,908 | $22.18 | – |
| 24 Feb 2025 | Jean-Marc Gilson | President, CEO & Director of Westlake Chemical Partners GP LLC | Private Acquisition | +167 | $24.75 | 11,708 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 148,107 | 0.4% | 8.6 |
| 15 Oct 2026 | 143,905 | 0.4% | 5.9 |
| 30 Sep 2026 | 138,343 | 0.4% | 6.9 |
| 15 Sep 2026 | 133,662 | 0.4% | 6.2 |
| 31 Aug 2026 | 134,745 | 0.4% | 5.1 |
| 14 Aug 2026 | 120,891 | 0.3% | 2.4 |
No comments yet — be the first to weigh in on WLKP.
Sign in to join the discussion.